Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
On March 26, 2012, the U.S. Supreme Court issued a much anticipated GVR (grant [certiorari], vacate and remand) order in the Association for Molecular Pathology v. the United States Patent Office (a.k.a. ACLU v. Myriad), remanding the case to the Federal Circuit for reevaluation in light of the Supreme Courts' recent decision in Mayo Medical Laboratories v. Prometheus Laboratories 566 U.S. ____ (US 2012).
United StatesFood, Drugs, Healthcare, Life Sciences
On March 26, 2012, the U.S. Supreme Court issued a much
anticipated GVR (grant [certiorari], vacate and remand) order in
the Association for Molecular Pathology v. the United States Patent
Office (a.k.a. ACLU v. Myriad), remanding the case to the Federal
Circuit for reevaluation in light of the Supreme Courts' recent
decision in Mayo Medical Laboratories v. Prometheus Laboratories
566 U.S. ____ (US 2012). The Prometheus decision has been
extensively discussed in the media but its possible impact on the
Federal Circuit decision in Myriad has received much less
attention.
Click
here to read the entire article as published by
Law360.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
